The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer
IN VITRO DIAGNOSTICS Aarhus University Hospital Exiqon AS Exiqon gets prostate cancer biomarkers from Aarhus Univ. Hosp. Aarhus University Hospital ’s Department of Molecular Medicine granted
IN VITRO DIAGNOSTICS Mergers & Acquisitions HalioDx Qiagen NV Qiagen Marseille SA Management of Qiagen NV division Qiagen Marseille SA have formed a new company, HalioDx , through a buy-out
Oxis Biotech, a subsidiary of Oxis International, has appointed of Steven Weldon chief financial officer, chief accounting officer and a member of its board of directors. A certified public accountant